Alnylam Pharmaceuticals | ALNY - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Arrowhead Research USD 8.56M 7.13M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Moderna USD 17M 54M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.6B 2.69B 2026-03
PTC Therapeutics USD 219.92M 38.3M 2026-03
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Takeda JPY 956.14B 79.79B 2026-06
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06
Xencor USD 42.23M 30.23M 2026-06